Abstract
Suicide is preventable, yet, in many settings, robust suicide prevention strategies are lacking. While a commercial determinants of health lens is increasingly being applied to industries important to the field of suicide prevention, the interplay between the vested interests of commercial actors and suicide has received limited attention. There is a need to shift attention to the “causes of the causes”, directing more attention to the ways that commercial determinants influence suicide and shape suicide prevention strategies. Such a shift in perspective, with an evidence base and precedents to draw upon, has transformative potential for research and policy agendas dedicated to understanding and addressing upstream modifiable determinants of suicide and self-harm. We propose a framework intended to help guide efforts to conceptualise, research, and address the commercial determinants of suicide and their inequitable distribution. We hope these ideas and lines of inquiry help catalyse the building of more bridges across disciplines and open spaces for further debate and discussion as to how to take such an agenda forward.
| Original language | English |
|---|---|
| Pages (from-to) | 363-370 |
| Number of pages | 8 |
| Journal | Lancet Psychiatry |
| Volume | 10 |
| Issue number | 5 |
| Early online date | 2 Apr 2023 |
| DOIs | |
| Publication status | Published - 1 May 2023 |
Bibliographical note
Funding Information:MCIvS, MPet, and JC have funding through and are co-investigators in the SPECTRUM consortium which is funded by the UK Prevention Research Partnership, a consortium of UK funders (UK research and innovation research councils [Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and Natural Environment Research Council], charities [British Heart Foundation, Cancer Research UK, the Wellcome Trust, and The Health Foundation], and government [Scottish Government Chief Scientist Office, Health and Care Research Wales, NIHR, and Public Health Agency]). NM (co-investigator) and MPet (principal investigator) have grant funding from the NIHR “Three Schools” Mental Health Programme. MCIvS is funded by the NIHR Doctoral Fellowship (NIHR3000156) and her research is also partially supported by the NIHR Applied Research Collaboration North Thames. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. DK is funded through the Elizabeth Blackwell Institute for Health Research at the University of Bristol, UK, which is supported by the Wellcome Trust. DK is also in receipt of a grant from the CPSP. LS is supported by the CPSP. The CPSP is funded by a grant from Open Philanthropy, at the recommendation of GiveWell, CA, USA.
Publisher Copyright:
© 2023 Elsevier Ltd
Research Groups and Themes
- SASH
Keywords
- SASH
Access to Document
- Full-text PDF (accepted author manuscript)
This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Elsevier at https://doi.org/10.1016/S2215-0366(23)00043-3. Please refer to any applicable terms of use of the publisher.